Advertisement

Role of Complement in Ethanol-Induced Liver Injury

  • Michele T. Pritchard
  • Megan R. McMullen
  • M. Edward Medof
  • Abram Stavitsky
  • Laura E. Nagy
Chapter
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 632)

Abstract

The complement cascade is a phylogenetically ancient part of our immune system and is critical to an organism’s ability to ward off infection. Interest in a possible role for the complement system in the development of ethanol-induced liver injury was inspired by the large body of data implicating the complement system in the development of acute and chronic inflammatory responses to bacteria/bacterial products, as well as in response to cell injury, both hallmarks of ethanol-induced liver injury. Recent investigations have demonstrated that complement is involved in the pathogenesis of ethanol-induced liver injury. Here we review the available data on the contribution of complement to ethanol-induced liver injury and then discuss the potential mechanisms by which the essential roles of complement in protecting the host from infection and facilitating wound healing may contribute to and/or protect from the pathogenesis of alcohol-induced liver injury.

Keywords

Kupffer Cell Alcoholic Liver Disease Ethanol Exposure Complement Pathway Chronic Ethanol 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Acknowledgments

This work was supported by NIH grants AA013868 and AA11975 to LEN and AI23598 MEM.

References

  1. Adachi, Y, Bradford, BU, Gao, W, Bojes, HK, and Thurman, RG, (1994) Inactivation of Kupffer cells prevents early alcohol-induced liver injury, Hepatology 20, 453–460PubMedCrossRefGoogle Scholar
  2. Addis-Lieser, E, Kohl, J, and Chiaramonte, MG, (2005) Opposing regulatory roles of complement factor 5 in the development of bleomycin-induced pulmonary fibrosis, Journal of Immunology 175, 1894–1902Google Scholar
  3. Apte, UM, McRee, R, and Ramaiah, SK, (2004) Hepatocyte proliferation is the possible mechanism for the transient decrease in liver injury during steatosis stage of alcoholic liver disease, Toxicologic Pathology 32, 567–576PubMedCrossRefGoogle Scholar
  4. Bode, C, Kugler, V, and Bode, JC, (1987) Endotoxemia in patients with alcoholic and non-alcoholic cirrhosis and in subjects with no evidence of chronic liver disease following acute alcohol excess, Journal of Hepatology 4, 8–14PubMedCrossRefGoogle Scholar
  5. Botto, M and Walport, MJ, (2002) C1q, autoimmunity and apoptosis, Immunobiology 205, 395–406PubMedCrossRefGoogle Scholar
  6. Botto, M, Dell’Agnola, C, Bygrave, AE, Thompson, EM, Cook, HT, Petry, F, Loos, M, Pandolfi, PP, and Walport, MJ, (1998) Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies, Nature Genetics 19, 56–59PubMedCrossRefGoogle Scholar
  7. Bykov, IL, Vakeva, A, Jarvelainen, HA, Meri, S, and Lindros, KO, (2004) Protective function of complement against alcohol-induced rat liver damage, International Immunopharmacology 4, 1445–1454PubMedCrossRefGoogle Scholar
  8. Bykov, I, Junnikkala, S, Pekna, M, Lindros, KO, and Meri, S, (2006) Complement C3 contributes to ethanol-induced liver steatosis in mice, Annals of Medicine 38, 280–286PubMedCrossRefGoogle Scholar
  9. Bykov, I, Jauhiainen, M, Olkkonen, VM, Saarikoski, ST, Ehnholm, C, Junnikkala, S, Vakeva, A, Lindros, KO, and Meri, S, (2007a) Hepatic gene expression and lipid parameters in complement C3(–/–) mice that do not develop ethanol-induced steatosis, Journal of Hepatology 46, 907–914CrossRefGoogle Scholar
  10. Bykov, I, Junnikkala, S, Pekna, M, Lindros, KO, and Meri, S, (2007b) Effect of chronic ethanol consumption on the expression of complement components and acute-phase proteins in liver, Clinical Immunology 124, 213–220CrossRefGoogle Scholar
  11. Cianflone, K, Xia, Z, and Chen, LY, (2003) Critical review of acylation-stimulating protein physiology in humans and rodents, Biochimica et Biophysica Acta 1609, 127–143PubMedCrossRefGoogle Scholar
  12. Daveau, M, Benard, M, Scotte, M, Schouft, MT, Hiron, M, Francois, A, Salier, JP, and Fontaine, M, (2004) Expression of a functional C5a receptor in regenerating hepatocytes and its involvement in a proliferative signaling pathway in rat, Journal of Immunology 173, 3418–3424Google Scholar
  13. Diehl, AM, (2005) Recent events in alcoholic liver disease V. effects of ethanol on liver regeneration, American Journal of Physiology Gastrointestinal and Liver Physiology 288, G1–G6PubMedCrossRefGoogle Scholar
  14. DiScipio, RG, Daffern, PJ, Jagels, MA, Broide, DH, and Sriramarao, P, (1999) A comparison of C3a and C5a-mediated stable adhesion of rolling eosinophils in postcapillary venules and transendothelial migration in vitro and in vivo, Journal of Immunology 162, 1127–1136Google Scholar
  15. Elward, K, Griffiths, M, Mizuno, M, Harris, CL, Neal, JW, Morgan, BP, and Gasque, P, (2005) CD46 plays a key role in tailoring innate immune recognition of apoptotic and necrotic cells, Journal of Biological Chemistry 280, 36342–36354PubMedCrossRefGoogle Scholar
  16. Fischer, WH and Hugli, TE, (1997) Regulation of B cell functions by C3a and C3a(desArg): suppression of TNF-alpha, IL-6, and the polyclonal immune response, Journal of Immunology 159, 4279–4286Google Scholar
  17. Friedman, SL, (2000) Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury, Journal of Biological Chemistry 275, 2247–2250PubMedCrossRefGoogle Scholar
  18. Fukui, H, Brauner, B, Bode, J, and Bode, C, (1991) Plasma endotoxin concentrations in patients with alcoholic and nonalcoholic liver disease: reevaluation with an improved chromogenic assay, Journal of Hepatology 12, 162–169PubMedCrossRefGoogle Scholar
  19. Gasque, P, (2004) Complement: a unique innate immune sensor for danger signals, Molecular Immunology 41, 1089–1098PubMedCrossRefGoogle Scholar
  20. Gressner, AM and Bachem, MG, (1995) Molecular mechanisms of liver fibrogenesis-a homage to the role of activated fat-storing cells, Digestion 56, 335–346PubMedCrossRefGoogle Scholar
  21. Halperin, JA, Taratuska, A, and Nicholson-Weller, A, (1993) Terminal complement complex C5b-9 stimulates mitogenesis in 3T3 cells, Journal of Clinical Investigation 91, 1974–1978PubMedCrossRefGoogle Scholar
  22. Hillebrandt, S, Wasmuth, HE, Weiskirchen, R, Hellerbrand, C, Keppeler, H, Werth, A, Schirin-Sokhan, R, Wilkens, G, Geier, A, Lorenzen, J, Kohl, J, Gressner, AM, Matern, S, and Lammert, F, (2005) Complement factor 5 is a quantitative trait gene that modifies liver fibrogenesis in mice and humans, Nature Genetics 37, 835–843PubMedCrossRefGoogle Scholar
  23. Hoek, JB and Pastorino, JG, (2002) Ethanol, oxidative stress, and cytokine-induced liver cell injury, Alcohol 27, 63–68PubMedCrossRefGoogle Scholar
  24. Huber-Lang, M, Sarma, JV, Zetoune, FS, Rittirsch, D, Neff, TA, McGuire, SR, Lambris, JD, Warner, RL, Flierl, MA, Hoesel, LM, Gebhard, F, Younger, JG, Drouin, SM, Wetsel, RA, and Ward, PA, (2006) Generation of C5a in the absence of C3: a new complement activation pathway, Nature Medicine 12, 682–687PubMedCrossRefGoogle Scholar
  25. Jaeschke, H, Gores, GJ, Cederbaum, AI, Hinson, JA, Pessayre, D, and Lemasters, JJ, (2002) Mechanisms of hepatotoxicity, Toxicological Sciences 65, 166–176PubMedCrossRefGoogle Scholar
  26. Jarvelainen, HA, Vakeva, A, Lindros, KO, and Meri, S, (2002) Activation of complement components and reduced regulator expression in alcohol-induced liver injury in the rat, Clinical Immunology 105, 57–63PubMedCrossRefGoogle Scholar
  27. Jauneau, AC, Ischenko, A, Chan, P, and Fontaine, M, (2003) Complement component anaphylatoxins upregulate chemokine expression by human astrocytes, FEBS Letters 537, 17–22PubMedCrossRefGoogle Scholar
  28. Kildsgaard, J, Zsigmond, E, Chan, L, and Wetsel, RA, (1999) A critical evaluation of the putative role of C3adesArg (ASP) in lipid metabolism and hyperapobetalipoproteinemia, Molecular Immunology 36, 869–876PubMedCrossRefGoogle Scholar
  29. Kildsgaard, J, Hollmann, TJ, Matthews, KW, Bian, K, Murad, F, and Wetsel, RA, (2000) Cutting edge: targeted disruption of the C3a receptor gene demonstrates a novel protective anti-inflammatory role for C3a in endotoxin-shock, Journal of Immunology 165, 5406–5409Google Scholar
  30. Koch, CA, Kanazawa, A, Nishitai, R, Knudsen, BE, Ogata, K, Plummer, TB, Butters, K, and Platt, JL, (2005) Intrinsic resistance of hepatocytes to complement-mediated injury, Journal of Immunology 174, 7302–7309Google Scholar
  31. Lieber, CS, (1994) Alcohol and the liver: 1994 update, Gastroenterology 106, 1085–1105PubMedGoogle Scholar
  32. Lin, F, Fukuoka, Y, Spicer, A, Ohta, R, Okada, N, Harris, CL, Emancipator, SN, and Medof, ME, (2001) Tissue distribution of products of the mouse decay-accelerating factor (DAF) genes. Exploitation of a Daf1 knock-out mouse and site-specific monoclonal antibodies, Immunology 104, 215–225PubMedCrossRefGoogle Scholar
  33. Markiewski, MM, Mastellos, D, Tudoran, R, DeAngelis, RA, Strey, CW, Franchini, S, Wetsel, RA, Erdei, A, and Lambris, JD, (2004) C3a and C3b activation products of the third component of complement (C3) are critical for normal liver recovery after toxic injury, Journal of Immunology 173, 747–754Google Scholar
  34. Martinez-Hernandez, A and Amenta, PS, (1993) The hepatic extracellular matrix II. Ontogenesis, regeneration and cirrhosis, Virchows Archiv A Pathological Anatomy 423, 77–84CrossRefGoogle Scholar
  35. Mastellos, D, Papadimitriou, JC, Franchini, S, Tsonis, PA, and Lambris, JD, (2001) A novel role of complement: mice deficient in the fifth component of complement (C5) exhibit impaired liver regeneration, Journal of Immunology 166, 2479–2486Google Scholar
  36. Mastellos, D, Prechl, J, Laszlo, G, Papp, K, Olah, E, Argyropoulos, E, Franchini, S, Tudoran, R, Markiewski, M, Lambris, JD, and Erdei, A, (2004) Novel monoclonal antibodies against mouse C3 interfering with complement activation: description of fine specificity and applications to various immunoassays, Molecular Immunology 40, 1213–1221PubMedCrossRefGoogle Scholar
  37. Medzhitov, R and Janeway, CA Jr, (2002) Decoding the patterns of self and nonself by the innate immune system, Science 296, 298–300PubMedCrossRefGoogle Scholar
  38. Michalopoulos, GK and DeFrances, MC, (1997) Liver regeneration, Science 276, 60–66PubMedCrossRefGoogle Scholar
  39. Minagawa, M, Deng, Q, Liu, ZX, Tsukamoto, H, and Dennert, G, (2004) Activated natural killer T cells induce liver injury by Fas and tumor necrosis factor-alpha during alcohol consumption, Gastroenterology 126, 1387–1399PubMedCrossRefGoogle Scholar
  40. Monsinjon, T, Gasque, P, Chan, P, Ischenko, A, Brady, JJ, and Fontaine, MC, (2003) Regulation by complement C3a and C5a anaphylatoxins of cytokine production in human umbilical vein endothelial cells, FASEB Journal 17, 1003–1014PubMedCrossRefGoogle Scholar
  41. Nagy, LE, (2003) New insights into the role of the innate immune response in the development of alcoholic liver disease. Experimantal Biology and Medicine 228, 882–890Google Scholar
  42. Nagy, LE, (2004) Molecular aspects of alcohol metabolism. Annual Review Nutrition 24, 55–78CrossRefGoogle Scholar
  43. Nanji, AA, Khettry, U, Sadrzadeh, SMH, and Yamanaka, T, (1993) Severity of liver injury in experimental alcoholic liver disease: Correlation with plasma endotoxin, prostaglandin E2, leukotriene B4 and thromboxane B2, American Journal of Pathology 142, 367–373PubMedGoogle Scholar
  44. Pritchard, MT, McMullen, MR, Stavitsky, AB, Cohen, JI, Lin, F, Medof, ME, and Nagy, LE, (2007) Differential contributions of C3, C5, and decay-accelerating factor to ethanol-induced fatty liver in mice, Gastroenterology 132, 1117–1126PubMedCrossRefGoogle Scholar
  45. Raghow, R, (1994) The role of extracellular matrix in postinflammatory wound healing and fibrosis, FASEB Journal 8, 823–831PubMedGoogle Scholar
  46. Schieferdecker, HL, Schlaf, G, Jungermann, K, and Gotze, O, (2001) Functions of anaphylatoxin C5a in rat liver: direct and indirect actions on nonparenchymal and parenchymal cells, International Immunopharmacology 1, 469–481PubMedCrossRefGoogle Scholar
  47. Strey, CW, Markiewski, M, Mastellos, D, Tudoran, R, Spruce, LA, Greenbaum, LE, and Lambris, JD, (2003) The proinflammatory mediators C3a and C5a are essential for liver regeneration, Journal of Experimental Medicine 198, 913–923PubMedCrossRefGoogle Scholar
  48. Takabayashi, T, Vannier, E, Clark, BD, Margolis, NH, Dinarello, CA, Burke, JF, and Gelfand, JA, (1996) A new biologic role for C3a and C3a desArg: regulation of TNF-alpha and IL-1 beta synthesis, Journal of Immunology 156, 3455–3460Google Scholar
  49. Takabayashi, T, Vannier, E, Burke, JF, Tompkins, RG, Gelfand, JA, and Clark, BD, (1998) Both C3a and C3a(desArg) regulate interleukin-6 synthesis in human peripheral blood mononuclear cells, Journal of Infectious Diseases 177, 1622–1628PubMedCrossRefGoogle Scholar
  50. Thurman, RG, (1998) Mechanisms of Hepatic Toxicity II. Alcoholic liver injury involves activation of Kupffer cells by endotoxin, American Journal of Physiology 275, G605–G611PubMedGoogle Scholar
  51. Tilg, H and Diehl, AM, (2000) Cytokines in alcoholic and nonalcoholic steatohepatitis, New England Journal of Medicine 343, 1467–1476PubMedCrossRefGoogle Scholar
  52. Tuma, DJ and Casey, CA, (2003) Dangerous byproducts of alcohol breakdown – focus on adducts, Alcohol Research and Health 27, 285–290PubMedGoogle Scholar
  53. Walport, MJ, (2001a) Complement. First of two parts, New England Journal of Medicine 344, 1058–1066CrossRefGoogle Scholar
  54. Walport, MJ, (2001b) Complement. Second of two parts, New England Journal of Medicine 344, 1140–1144CrossRefGoogle Scholar
  55. Walport, MJ, (2002) Complement and systemic lupus erythematosus, Arthritis Research 4, S279–S293PubMedCrossRefGoogle Scholar
  56. Wetsel, RA and Kolb, WP, (1983) Expression of C5a-like biological activities by the fifth component of human complement (C5) upon limited digestion with noncomplement enzymes without release of polypeptide fragments, Journal of Experimental Medicine 157, 2029–2048PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Michele T. Pritchard
    • 1
  • Megan R. McMullen
  • M. Edward Medof
    • 4
  • Abram Stavitsky
    • 3
  • Laura E. Nagy
    • 2
  1. 1.Department of PathobiologyCleveland ClinicClevelandUSA
  2. 2.Department of GastroenterologyCleveland ClinicClevelandUSA
  3. 3.Department of Molecular Biology and MicrobiologyCase Western Reserve UniversityClevelandUSA
  4. 4.Department of PathologyCase Western Reserve UniversityClevelandUSA

Personalised recommendations